Juha Rinne
jurin@utu.fi +358 50 441 2400 |
- Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease (2023)
- Journal of Neurology
- APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly (2023)
- Alzheimer's Research and Therapy
- Effect of xenon on brain injury, neurological outcome, and survival in patients after aneurysmal subarachnoid hemorrhage-study protocol for a randomized clinical trial (2023)
- Trials
- Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease (2023)
- Neurobiology of Disease
- Impaired Early Insulin Response to Glucose Load Predicts Episodic Memory Decline: A 10-Year Population-Based Cohort Follow-Up of 45-74-Year-Old Men and Women (2023)
- Journal of Alzheimer's Disease
- Insulin resistance and body mass index are associated with TSPO PET in cognitively unimpaired elderly (2023)
- Journal of Cerebral Blood Flow and Metabolism
- Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial (2023)
- Movement Disorders
- Quantification of the purinergic P2X(7) receptor with [C-11]SMW139 improves through correction for brain-penetrating radiometabolites (2023)
- Journal of Cerebral Blood Flow and Metabolism
- Quantitative Perfusion Imaging with Total-Body PET (2023)
- Journal of Nuclear Medicine
- The role of brain integrity in the association between occupational complexity and cognitive performance in subjects with increased risk of dementia (2023)
- Gerontology
- Alzheimerin taudin lääkkeet (2022) Farmakologia ja toksikologia Rinne Juha, Koulu Markku
- ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease - Study Protocol and Baseline Characteristics (2022)
- Frontiers in Neurology
- Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up (2022)
- Neurology
- Atlas of type 2 dopamine receptors in the human brain: Age and sex dependent variability in a large PET cohort (2022)
- NeuroImage
- Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [F-18]FMPEP-d(2) (2022)
- Movement Disorders
- Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study (2022)
- EJNMMI Research
- Differences in brain changes between adults with childhood-onset epilepsy and controls: A prospective population-based study (2022)
- Acta Neurologica Scandinavica
- Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation (2022)
- EJNMMI Research
- Direct Comparison of [18F]F-DPA with [18F]DPA-714 and [11C]PBR28 for Neuroinflammation Imaging in the same Alzheimer’s Disease Model Mice and Healthy Controls (2022)
- Molecular Imaging and Biology
- Education as a moderator of middle-age cardiovascular risk factor-old-age cognition relationships: testing cognitive reserve hypothesis in epidemiological study (2022)
- Age and Ageing